Zobrazeno 1 - 10
of 42
pro vyhledávání: '"I J, Mitchell"'
Autor:
Dr. Rhodri E. Owen, Dr. Fernando Cortezon‐Tamarit, Dr. David G. Calatayud, Enid A. Evans, Samuel I. J. Mitchell, Dr. Boyang Mao, Dr. Francisco J. Palomares, Dr. John Mitchels, Dr. Pawel Plucinski, Prof. Davide Mattia, Prof. Matthew D. Jones, Prof. Sofia I. Pascu
Publikováno v:
ChemistryOpen, Vol 9, Iss 2, Pp 242-252 (2020)
Abstract We report on the design and testing of new graphite and graphene oxide‐based extended π‐conjugated synthetic scaffolds for applications in sustainable chemistry transformations. Nanoparticle‐functionalised carbonaceous catalysts for n
Externí odkaz:
https://doaj.org/article/a6d519fd22a6475e8dc3f85adf21ee2a
Autor:
David G. Calatayud, Sofia I. Pascu, Boyang Mao, Francisco Palomares, Fernando Cortezon-Tamarit, Rhodri E. Owen, Davide Mattia, Enid A. Evans, Pawel Plucinski, Matthew D. Jones, Samuel I. J. Mitchell, John M. Mitchels
Publikováno v:
ChemistryOpen, Vol 9, Iss 2, Pp 242-252 (2020)
We report on the design and testing of new graphite and graphene oxide‐based extended π‐conjugated synthetic scaffolds for applications in sustainable chemistry transformations. Nanoparticle‐functionalised carbonaceous catalysts for new Fische
Autor:
Rhodri E, Owen, Fernando, Cortezon-Tamarit, David G, Calatayud, Enid A, Evans, Samuel I J, Mitchell, Boyang, Mao, Francisco J, Palomares, John, Mitchels, Pawel, Plucinski, Davide, Mattia, Matthew D, Jones, Sofia I, Pascu
Publikováno v:
ChemistryOpen
We report on the design and testing of new graphite and graphene oxide‐based extended π‐conjugated synthetic scaffolds for applications in sustainable chemistry transformations. Nanoparticle‐functionalised carbonaceous catalysts for new Fische
Autor:
Alan R. Crossman, I. J. Mitchell, Geoffrey N. Woodruff, Jonathan M. Brotchie, Yannick P. Maneuf
Publikováno v:
Brain Research. 683:102-108
Parkinson's disease is characterized by an increased excitatory amino acid transmission in the internal segment of the globus pallidus and the substantia nigra pars reticulata. The effects of the kappa receptor agonist enadoline (CI-977) on glutamate
Publikováno v:
Experimental Neurology. 125:65-71
In the MPTP-treated primate model of Parkinson's disease, loss of dopaminergic afferents to the striatum leads to increased activity in striatal efferents to the external segment of the globus pallidus. This pathway utilizes both GABA and enkephalin
Publikováno v:
Brain. 115:809-824
The neural mechanisms that underlie both the anti-parkinsonian effects of dopamine agonists and dopamine agonist-induced dyskinesia were studied in parkinsonian primates, using the regional brain uptake of [3H]2-deoxyglucose (2-DG). Parkinsonian symp
Publikováno v:
Movement Disorders. 7:32-37
The neural mechanisms that mediate a primate model of tardive dyskinesia have been investigated using the 2-deoxyglucose (2-DG) uptake technique. Three groups of Cebus monkeys were used. Some of the animals received long-term neuroleptic treatment. T
Autor:
I. J. Mitchell, S. Boyce, R. Luquin, M.A. Sambrook, C.E. Clarke, R.G. Robertson, Alan R. Crossman
Publikováno v:
Movement Disorders. 5:49-54
The neural mechanisms that mediate dystonia were investigated in a novel experimental primate model of dopamine agonist-induced dystonia. This condition was produced by long-term (15 months) dopamine agonist therapy of a macaque monkey that had been
Publikováno v:
Advances in Behavioral Biology ISBN: 9781489901965
Idiopathic Parkinson’s disease is a neurodegenerative disease of the dopaminergic neurons of the substantia nigra pars compacta. It is characterised by a triad of symptoms, bradykinesia, rigidity and resting tremor. Interspecies variation in the re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a00b0dd133c0f7f20c6e03424d014d2a
https://doi.org/10.1007/978-1-4899-0194-1_61
https://doi.org/10.1007/978-1-4899-0194-1_61
Publikováno v:
Behavioural pharmacology. 6(5-6)
We have investigated the potential of alleviating parkinsonian symptoms by manipulating excitatory amino acid (EAA) transmission, by several different pharmacological means, in a novel primate model of parkinsonism. The model is based on a two-stage